Bullish on INJ's RWA pivot and ETF catalysts

I just finished reading the new $INJ whitepaper, and I feel like this move by Injective ($INJ) really feels like an old tree sprouting new leaves! 🧐 Your impression of $INJ might still be stuck on "derivatives DEX public chain," but after diving deeper recently, I discovered it quietly accomplished something major: releasing a completely revamped whitepaper for the first time since 2018, directly reshaping its positioning into a "dedicated L1 for institutional finance and RWAs." 🔥 From asset issuance and on-chain order book trading to AI agent finance and tokenized clearing, the entire lifecycle is built specifically for RWAs and institutional entry points. This isn't just issuing a whitepaper and making empty promises. After searching around, I found that its activity density over the past 6 weeks is incredibly high: 1️⃣ Compliance and institutional channels are rolling out comprehensively: Meridian upgrade, SEC-registered transfer agent, MiCA registration, and even integration with Robinhood; 2️⃣ INJ ETF progress: Both 21Shares and Canary's INJ ETF applications are being revised and submitted intensively; today, the CEO revealed that they will go live very soon; 3️⃣ Extremely clean token structure: Tokens are 100% fully circulating, with no VC unlock sell pressure, and the whitepaper explicitly states there is a buyback plan! An established public chain with a compliance moat, fully circulating tokens, and a thoroughly iterated technical whitepaper is quietly building momentum in the institutional RWA track. Will it be the next one to undergo a value revaluation? 🧐 DYOR, keep an eye on it! #INJ #Injective #RWA #Crypto